APA (7th ed.) Citation

L, H., A, E., CL, G., C, U., L, L., M, P., . . . AC, O. (2021). Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma. Nature cancer, 2(7), 693. https://doi.org/10.1038/s43018-021-00221-9

Chicago Style (17th ed.) Citation

L, Haas, et al. "Acquired Resistance to Anti-MAPK Targeted Therapy Confers an Immune-evasive Tumor Microenvironment and Cross-resistance to Immunotherapy in Melanoma." Nature Cancer 2, no. 7 (2021): 693. https://doi.org/10.1038/s43018-021-00221-9.

MLA (9th ed.) Citation

L, Haas, et al. "Acquired Resistance to Anti-MAPK Targeted Therapy Confers an Immune-evasive Tumor Microenvironment and Cross-resistance to Immunotherapy in Melanoma." Nature Cancer, vol. 2, no. 7, 2021, p. 693, https://doi.org/10.1038/s43018-021-00221-9.